Tempus AI (NASDAQ:TEM) Shares Gap Up – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM) shares gapped up before the market opened on Wednesday . The stock had previously closed at $61.85, but opened at $64.30. Tempus AI shares last traded at $67.59, with a volume of 5,013,447 shares traded.

Analyst Upgrades and Downgrades

TEM has been the topic of several research analyst reports. Needham & Company LLC reiterated a “buy” rating and issued a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and lifted their target price for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Loop Capital lowered their target price on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Guggenheim started coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Finally, TD Cowen restated a “buy” rating and set a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a report on Wednesday. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $58.55.

Tempus AI Stock Up 4.7 %

The company has a 50-day moving average price of $44.36 and a 200-day moving average price of $48.84. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 20,000 shares of the stock in a transaction on Tuesday, February 4th. The stock was sold at an average price of $62.50, for a total transaction of $1,250,000.00. Following the sale, the chief operating officer now owns 962,442 shares in the company, valued at approximately $60,152,625. This represents a 2.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the business’s stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the transaction, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. This trade represents a 2.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,058,072 shares of company stock worth $90,719,375.

Institutional Trading of Tempus AI

A number of large investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI during the 3rd quarter valued at $30,000. FNY Investment Advisers LLC bought a new stake in Tempus AI during the fourth quarter valued at $67,000. IFP Advisors Inc acquired a new stake in Tempus AI during the fourth quarter worth about $76,000. US Bancorp DE bought a new position in Tempus AI in the fourth quarter worth about $80,000. Finally, Vestor Capital LLC acquired a new position in Tempus AI in the third quarter valued at approximately $153,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.